RGC Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: November 07, 2025

Report Source: 2025 Annual Report

Regencell Bioscience Holdings Ltd

Regencell Bioscience Holdings Ltd. Stock Analysis RGC

United States Health Care Large Cap Report:
Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company employs 10 full-time employees The company went IPO on 2021-07-16. The firm launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
Read More

Regencell Bioscience Holdings Ltd (RGC) Chart

Key Statistics of Regencell Bioscience Holdings Ltd (RGC)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$26.51$30.00

Today's Open

$26.51

Volume

119.75K

P/E Ratio (TTM)

-

52 Week Range

$7.89$83.60

Market Cap

13.48B

Avg. Volume

104.24K

Dividend Yield

-

Financial Metrics & Statements of Regencell Bioscience Holdings Ltd (RGC)

Community-Curated Collections with Regencell Bioscience Holdings Ltd (RGC) ( With RGC )

View All

Community-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.

FAQ's for Regencell Bioscience Holdings Ltd (RGC)

  • According to Musaffa’s Shariah screening methodology, Regencell Bioscience Holdings Ltd (RGC) is currently classified as NOT HALAL as of November 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.